BioMendics, LLC is a wound healing technology company using liquid crystalline biomimetics for the treatment of chronic wounds. This proprietary platform technology creates a partially ordered film across the surface of the skin while mimicking growth factors to target all phases of the wound healing process. The technology accelerates wound closure while providing a safe, cost effective & easy to use consumer product.
The company received the $25,000 Innovation Fund award in December 2014 and is using the funds for additional patent protection, chemical synthesis and experiments toward FDA approval.
Website: https://www.biomendics.com/
